Home › Funds › Longaeva Partners L.P. › ABBV

Longaeva Partners L.P. position in ABBV

ABBVIE INC · Health Care

Longaeva Partners L.P. reported holding 143,436 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$37.5M, representing 0.95% of its reported portfolio and ranking #16 among its reported holdings. Longaeva Partners L.P. has disclosed ABBV holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)143.44K sh
Reported value held$37.52M
Portfolio Weight0.95%
First reportedQ2 2026
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Longaeva Partners L.P.'s ABBV position evolved

Longaeva Partners L.P. first disclosed a stake in ABBV in Q2 2026 at 67,093 shares (US$16.9M). The position peaked in Q3 2026 at 143,436 shares, worth US$37.5M. Across 2 filings, Longaeva Partners L.P. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 143,436 shares valued at US$37.5M — an increase of 76,343 shares quarter over quarter.. Notable position changes include a 114% increase in Q3 2026 (shares rose 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 67.09K $16.88M New
Q3 2026 143.44K $37.52M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 32 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$38.97B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Longaeva Partners L.P. held ABBV?

Longaeva Partners L.P. has disclosed ABBV holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Longaeva Partners L.P.'s current position in ABBV?

As of Q3 2026, Longaeva Partners L.P. holds 143.44K shares of ABBV (ABBVIE INC), valued at $37.52M, representing 0.95% of its reported portfolio and ranking #16.

Has Longaeva Partners L.P. been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Longaeva Partners L.P. increased its position in ABBV. The position peaked in Q3 2026 at 143.44K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.